
Organization · Private Equity
1315 Capital
1315 Capital is a private equity firm based in Philadelphia, Pennsylvania, specializing in growth-stage investments in healthcare companies. The firm focuses on leveraging operational expertise to accelerate the growth of its portfolio companies.
Overview
What 1315 Capital does
What 1315 Capital is
1315 Capital is a private equity firm based in Philadelphia, Pennsylvania, specializing in growth-stage investments in healthcare companies. The firm focuses on leveraging operational expertise to accelerate the growth of its portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder
- Last reviewed
- March 3, 2026
Official channels
Find 1315 Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
1315 Capital as a funder
Investment thesis
1315 Capital invests exclusively in commercial-stage healthcare companies with significant growth potential. The firm leverages its operational expertise and industry knowledge to accelerate growth in its portfolio companies.
Focus narrative
1315 Capital invests in commercial-stage healthcare companies across various sectors, including healthcare services, pharmaceutical and medical technology products, pharmaceutical and medical technology outsourcing, and health and wellness. The firm seeks to partner with companies that have significant growth potential, leveraging its operational expertise and industry knowledge to accelerate growth.
Focus and fit
- Stages
- Growth Equity
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 35
Portfolio context
Notable portfolio companies include: Centurion Service Group: A leading medical equipment liquidation and resale platform specializing in auctions and facility liquidations. Biocoat: A specialty manufacturer of hydrophilic coatings used in medical devices, which has grown into a market leader in the U.S. under 1315 Capital's partnership. Colorescience: A premium skin health brand offering sun protection and corrective skincare products, which received investment during a pivotal time for growth. Onkos Surgical: An innovator in surgical orthopedic oncology solutions, including limb salvage implants and personalized 3D surgical planning. Reaction Biology: A preclinical contract research organization providing end-to-end drug discovery and early development assay services.
Connected ecosystem
Continue from 1315 Capital
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Common questions
What to know about 1315 Capital
Upseed classifies 1315 Capital under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.